James Irvin Healy is an American businessperson who has been at the head of 5 different companies. Presently, Dr. Healy occupies the position of Chairman for Y-mAbs Therapeutics, Inc., Chairman at CinCor Pharma, Inc. and Managing Partner at Sofinnova Investments, Inc., Managing Partner at Sofinnova Investments, Inc. (Investment Management), Managing General Partner at Sofinnova Venture Partners VII LP, Managing Partner at Sofinnova Management VI LLC and Managing Partner at Sofinnova Management VII LLC (which are all subsidiaries of Sofinnova Investments, Inc.). Dr. Healy is also Managing General Partner at Sofinnova Venture Partners VII LP, Managing Partner at Sofinnova Management VI LLC and Managing Partner at Sofinnova Management VII LLC and on the board of 6 other companies.

He previously was Independent Director at Humanigen, Inc., Manager at ISTA Pharmaceuticals, Inc., Associate at Sanderling Ventures, Chairman for Hyperion Therapeutics, Inc., Principal at Bayer Pharmaceuticals Corp., Principal at Lawrence Berkeley National Laboratory and Director at PregLem SA.

Dr. Healy received an undergraduate degree from the University of California, Berkeley and a doctorate from Stanford University School of Medicine.